, Columnist
Cancer Vaccine Shows Hope. Make the Investment.
Success requires investing in the kind of foundational research that becomes the basis for breakthroughs.
Success is a team effort.
Photographer: Dan Kitwood/Getty Images EuropeThis article is for subscribers only.
A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease: hope.
Pancreatic cancer is notorious for the swiftness with which is kills. So, when researchers offer data suggesting a personalized vaccine might be able to keep the cancer at bay for years, it’s worth paying attention to — even when the results are in just a handful of people.